{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:39:13Z","timestamp":1769758753045,"version":"3.49.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T00:00:00Z","timestamp":1436572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s11899-015-0274-1","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T09:59:35Z","timestamp":1436522375000},"page":"225-236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies"],"prefix":"10.1007","volume":"10","author":[{"given":"Marlise R.","family":"Luskin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Del Percio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison W.","family":"Loren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,11]]},"reference":[{"issue":"2","key":"274_CR1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jama.2010.923","volume":"304","author":"RC Reulen","year":"2010","unstructured":"Reulen RC et al. Long-term cause-specific mortality among survivors of childhood cancer. JAMA. 2010;304(2):172\u20139.","journal-title":"JAMA"},{"issue":"8","key":"274_CR2","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1200\/JCO.2008.20.2267","volume":"28","author":"M Tukenova","year":"2010","unstructured":"Tukenova M et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol. 2010;28(8):1308\u201315.","journal-title":"J Clin Oncol"},{"issue":"22","key":"274_CR3","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2013.6296","volume":"309","author":"MM Hudson","year":"2013","unstructured":"Hudson MM et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309(22):2371\u201381.","journal-title":"JAMA"},{"issue":"17","key":"274_CR4","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIR.0b013e3182a88099","volume":"128","author":"SE Lipshultz","year":"2013","unstructured":"Lipshultz SE et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American heart association. Circulation. 2013;128(17):1927\u201395.","journal-title":"Circulation"},{"key":"274_CR5","doi-asserted-by":"crossref","unstructured":"Lenihan DJ, Cardinale DM. Late cardiac effects of cancer treatment. J Clin Oncol. 2012;30(30):3657\u201364. This article represents a comprehensive review of the late cardiac toxicities occurring after cancer treatment.","DOI":"10.1200\/JCO.2012.45.2938"},{"issue":"29","key":"274_CR6","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","volume":"31","author":"GT Armstrong","year":"2013","unstructured":"Armstrong GT et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013;31(29):3673\u201380. This article describes the impact of traditional modifiable cardiovascular risk factors on risk for major cardiac events among adult survivors of childhood cancer.","journal-title":"J Clin Oncol"},{"issue":"5 Pt 1","key":"274_CR7","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1542\/peds.89.5.942","volume":"89","author":"LJ Steinherz","year":"1992","unstructured":"Steinherz LJ et al. Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the cardiology committee of the childrens cancer study group. Pediatrics. 1992;89(5 Pt 1):942\u20139.","journal-title":"Pediatrics"},{"issue":"8","key":"274_CR8","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/annonc\/mdr595","volume":"23","author":"E Sieswerda","year":"2012","unstructured":"Sieswerda E et al. The Dutch childhood oncology group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. Ann Oncol. 2012;23(8):2191\u20138.","journal-title":"Ann Oncol"},{"issue":"5","key":"274_CR9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2014.56.1373","volume":"33","author":"EJ Chow","year":"2015","unstructured":"Chow EJ et al. Individual prediction of heart failure among childhood cancer survivors. J Clin Oncol. 2015;33(5):394\u2013402. This article describes the creation and validation of a prediction model for heart failure among childhood cancer survivors.","journal-title":"J Clin Oncol"},{"issue":"13","key":"274_CR10","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1200\/JCO.2011.34.8987","volume":"30","author":"JG Blanco","year":"2012","unstructured":"Blanco JG et al. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes\u2014a report from the children\u2019s oncology group. J Clin Oncol. 2012;30(13):1415\u201321.","journal-title":"J Clin Oncol"},{"issue":"13","key":"274_CR11","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2010.34.3467","volume":"30","author":"H Visscher","year":"2012","unstructured":"Visscher H et al. Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol. 2012;30(13):1422\u20138.","journal-title":"J Clin Oncol"},{"issue":"19","key":"274_CR12","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1002\/cncr.28256","volume":"119","author":"SE Lipshultz","year":"2013","unstructured":"Lipshultz SE et al. Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia. Cancer. 2013;119(19):3555\u201362.","journal-title":"Cancer"},{"issue":"8","key":"274_CR13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/pbc.24505","volume":"60","author":"H Visscher","year":"2013","unstructured":"Visscher H et al. Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatr Blood Cancer. 2013;60(8):1375\u201381.","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"274_CR14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1200\/JCO.2013.50.3557","volume":"32","author":"X Wang","year":"2014","unstructured":"Wang X et al. Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children\u2019s oncology group. J Clin Oncol. 2014;32(7):647\u201353.","journal-title":"J Clin Oncol"},{"issue":"2","key":"274_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pcad.2010.04.002","volume":"53","author":"D Cardinale","year":"2010","unstructured":"Cardinale D, Sandri MT. Role of biomarkers in chemotherapy-induced cardiotoxicity. Prog Cardiovasc Dis. 2010;53(2):121\u20139.","journal-title":"Prog Cardiovasc Dis"},{"issue":"22","key":"274_CR16","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehq167","volume":"31","author":"Y D\u2019Alessandra","year":"2010","unstructured":"D\u2019Alessandra Y et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 2010;31(22):2765\u201373.","journal-title":"Eur Heart J"},{"issue":"4","key":"274_CR17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/cvr\/cvq148","volume":"87","author":"T Horie","year":"2010","unstructured":"Horie T et al. Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway. Cardiovasc Res. 2010;87(4):656\u201364.","journal-title":"Cardiovasc Res"},{"issue":"21","key":"274_CR18","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1200\/JCO.2009.26.7294","volume":"28","author":"J Walker","year":"2010","unstructured":"Walker J et al. Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging. J Clin Oncol. 2010;28(21):3429\u201336.","journal-title":"J Clin Oncol"},{"issue":"22","key":"274_CR19","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","volume":"57","author":"N Fallah-Rad","year":"2011","unstructured":"Fallah-Rad N et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol. 2011;57(22):2263\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"274_CR20","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.amjcard.2011.01.006","volume":"107","author":"H Sawaya","year":"2011","unstructured":"Sawaya H et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011;107(9):1375\u201380.","journal-title":"Am J Cardiol"},{"issue":"10","key":"274_CR21","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1200\/JCO.2010.30.3404","volume":"30","author":"SE Lipshultz","year":"2012","unstructured":"Lipshultz SE et al. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. J Clin Oncol. 2012;30(10):1042\u20139.","journal-title":"J Clin Oncol"},{"issue":"2","key":"274_CR22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10549-009-0730-5","volume":"122","author":"AH Blaes","year":"2010","unstructured":"Blaes AH et al. Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy. Breast Cancer Res Treat. 2010;122(2):585\u201390.","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"274_CR23","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","volume":"114","author":"D Cardinale","year":"2006","unstructured":"Cardinale D et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation. 2006;114(23):2474\u201381.","journal-title":"Circulation"},{"issue":"11","key":"274_CR24","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/cncr.21478","volume":"104","author":"H Nakamae","year":"2005","unstructured":"Nakamae H et al. Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone. Cancer. 2005;104(11):2492\u20138.","journal-title":"Cancer"},{"issue":"23","key":"274_CR25","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2013.02.072","volume":"61","author":"X Bosch","year":"2013","unstructured":"Bosch X et al. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (prevention of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies). J Am Coll Cardiol. 2013;61(23):2355\u201362. A prospective randomized trial demonstrating cardioprotection in patients receiving ACE-I and beta-blockers with chemotherapy.","journal-title":"J Am Coll Cardiol"},{"issue":"27","key":"274_CR26","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1200\/JCO.2005.15.107","volume":"23","author":"DC Bowers","year":"2005","unstructured":"Bowers DC et al. Stroke as a late treatment effect of Hodgkin\u2019s disease: a report from the childhood cancer survivor study. J Clin Oncol. 2005;23(27):6508\u201315.","journal-title":"J Clin Oncol"},{"issue":"13","key":"274_CR27","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jnci\/djp147","volume":"101","author":"ML Bruin De","year":"2009","unstructured":"De Bruin ML et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst. 2009;101(13):928\u201337.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"274_CR28","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/pbc.22664","volume":"55","author":"G Schellong","year":"2010","unstructured":"Schellong G et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer. 2010;55(6):1145\u201352.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"274_CR29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JCO.2006.07.0805","volume":"25","author":"PA Heidenreich","year":"2007","unstructured":"Heidenreich PA et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin\u2019s disease. J Clin Oncol. 2007;25(1):43\u20139.","journal-title":"J Clin Oncol"},{"issue":"32","key":"274_CR30","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1200\/JCO.2009.22.8460","volume":"27","author":"AB Chen","year":"2009","unstructured":"Chen AB et al. Cost effectiveness and screening interval of lipid screening in Hodgkin\u2019s lymphoma survivors. J Clin Oncol. 2009;27(32):5383\u20139.","journal-title":"J Clin Oncol"},{"issue":"9","key":"274_CR31","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.6004\/jnccn.2011.0086","volume":"9","author":"RT Hoppe","year":"2011","unstructured":"Hoppe RT et al. Hodgkin lymphoma. J Natl Compr Cancer Netw. 2011;9(9):1020\u201358.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"30","key":"274_CR32","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1200\/JCO.2005.02.7243","volume":"23","author":"WG Martin","year":"2005","unstructured":"Martin WG et al. Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin\u2019s lymphoma. J Clin Oncol. 2005;23(30):7614\u201320.","journal-title":"J Clin Oncol"},{"issue":"2","key":"274_CR33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1378\/chest.88.2.304","volume":"88","author":"AJ Gilson","year":"1985","unstructured":"Gilson AJ, Sahn SA. Reactivation of bleomycin lung toxicity following oxygen administration. A second response to corticosteroids. Chest. 1985;88(2):304\u20136.","journal-title":"Chest"},{"issue":"2","key":"274_CR34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0025-6196(12)60489-3","volume":"66","author":"TS Ingrassia 3rd","year":"1991","unstructured":"Ingrassia 3rd TS et al. Oxygen-exacerbated bleomycin pulmonary toxicity. Mayo Clin Proc. 1991;66(2):173\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"274_CR35","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0022-5347(01)62533-3","volume":"160","author":"SM Donat","year":"1998","unstructured":"Donat SM, Levy DA. Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary? J Urol. 1998;160(4):1347\u201352.","journal-title":"J Urol"},{"issue":"2","key":"274_CR36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.mayocp.2013.11.007","volume":"89","author":"BM Aakre","year":"2014","unstructured":"Aakre BM et al. Postoperative acute respiratory distress syndrome in patients with previous exposure to bleomycin. Mayo Clin Proc. 2014;89(2):181\u20139. This article demonstrates that the risk of post-operative ARDS in bleomycin-exposed patients is low, and may be related to smoking.","journal-title":"Mayo Clin Proc"},{"issue":"127","key":"274_CR37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1183\/09059180.00001912","volume":"22","author":"K Amraoui","year":"2013","unstructured":"Amraoui K et al. Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients. Eur Respir Rev. 2013;22(127):93\u20135.","journal-title":"Eur Respir Rev"},{"issue":"9","key":"274_CR38","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1182\/blood-2005-11-4541","volume":"107","author":"S Miyakoshi","year":"2006","unstructured":"Miyakoshi S et al. Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma. Blood. 2006;107(9):3492\u20134.","journal-title":"Blood"},{"issue":"22","key":"274_CR39","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1200\/JCO.2006.10.0164","volume":"25","author":"P Zappasodi","year":"2007","unstructured":"Zappasodi P et al. Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma. J Clin Oncol. 2007;25(22):3380\u20131.","journal-title":"J Clin Oncol"},{"issue":"6","key":"274_CR40","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.leu.2404207","volume":"20","author":"K Ohnishi","year":"2006","unstructured":"Ohnishi K et al. Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate. Leukemia. 2006;20(6):1162\u20134.","journal-title":"Leukemia"},{"issue":"8","key":"274_CR41","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.200705-715CR","volume":"176","author":"A Bergeron","year":"2007","unstructured":"Bergeron A et al. Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series. Am J Respir Crit Care Med. 2007;176(8):814\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"274_CR42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199108293250902","volume":"325","author":"SL Hancock","year":"1991","unstructured":"Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin\u2019s disease. N Engl J Med. 1991;325(9):599\u2013605.","journal-title":"N Engl J Med"},{"issue":"4","key":"274_CR43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ctrv.2003.12.003","volume":"30","author":"BA Jereczek-Fossa","year":"2004","unstructured":"Jereczek-Fossa BA et al. Radiotherapy-induced thyroid disorders. Cancer Treat Rev. 2004;30(4):369\u201384.","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"274_CR44","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jacr.2014.07.038","volume":"11","author":"CS Ha","year":"2014","unstructured":"Ha CS et al. ACR appropriateness criteria follow-up of Hodgkin lymphoma. J Am Coll Radiol. 2014;11(11):1026\u20131033.e3.","journal-title":"J Am Coll Radiol"},{"issue":"2","key":"274_CR45","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/blood-2008-08-173005","volume":"113","author":"JE Sanders","year":"2009","unstructured":"Sanders JE et al. Thyroid function following hematopoietic cell transplantation in children: 30 years\u2019 experience. Blood. 2009;113(2):306\u20138.","journal-title":"Blood"},{"issue":"3","key":"274_CR46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbmt.2011.12.519","volume":"18","author":"NS Majhail","year":"2012","unstructured":"Majhail NS et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012;18(3):348\u201371. This article represents a comprehensive review of short-term and long-term primary-care-based recommendations for recipients of hematopoietic cell transplantation.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"274_CR47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/humrep\/deg016","volume":"18","author":"WH Wallace","year":"2003","unstructured":"Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18(1):117\u201321.","journal-title":"Hum Reprod"},{"issue":"3","key":"274_CR48","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2004.11.038","volume":"62","author":"WH Wallace","year":"2005","unstructured":"Wallace WH et al. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62(3):738\u201344.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"274_CR49","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.fertnstert.2013.08.010","volume":"100","author":"ML Meistrich","year":"2013","unstructured":"Meistrich ML. Effects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril. 2013;100(5):1180\u20136.","journal-title":"Fertil Steril"},{"issue":"4","key":"274_CR50","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1054\/bjoc.1999.1000","volume":"82","author":"SJ Howell","year":"2000","unstructured":"Howell SJ et al. Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction. Br J Cancer. 2000;82(4):789\u201393.","journal-title":"Br J Cancer"},{"issue":"9","key":"274_CR51","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1210\/jc.2006-2744","volume":"92","author":"DM Greenfield","year":"2007","unstructured":"Greenfield DM et al. Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. J Clin Endocrinol Metab. 2007;92(9):3476\u201382.","journal-title":"J Clin Endocrinol Metab"},{"issue":"30","key":"274_CR52","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1200\/JCO.2012.41.8681","volume":"30","author":"ME Wood","year":"2012","unstructured":"Wood ME et al. Second malignant neoplasms: assessment and strategies for risk reduction. J Clin Oncol. 2012;30(30):3734\u201345. This article is a comprehensive overview of second cancers in adult-onset cancer survivors.","journal-title":"J Clin Oncol"},{"issue":"5","key":"274_CR53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrclinonc.2013.41","volume":"10","author":"LB Travis","year":"2013","unstructured":"Travis LB et al. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol. 2013;10(5):289\u2013301.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"274_CR54","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2002.08.021","volume":"20","author":"AK Ng","year":"2002","unstructured":"Ng AK et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin\u2019s disease treated at age 50 or younger. J Clin Oncol. 2002;20(8):2101\u20138.","journal-title":"J Clin Oncol"},{"issue":"18","key":"274_CR55","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","volume":"21","author":"BM Aleman","year":"2003","unstructured":"Aleman BM et al. Long-term cause-specific mortality of patients treated for Hodgkin\u2019s disease. J Clin Oncol. 2003;21(18):3431\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"274_CR56","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2000.18.3.487","volume":"18","author":"FE Leeuwen van","year":"2000","unstructured":"van Leeuwen FE et al. Long-term risk of second malignancy in survivors of Hodgkin\u2019s disease treated during adolescence or young adulthood. J Clin Oncol. 2000;18(3):487\u201397.","journal-title":"J Clin Oncol"},{"issue":"7540","key":"274_CR57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","volume":"518","author":"TN Wong","year":"2015","unstructured":"Wong TN et al. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature. 2015;518(7540):552\u20135. This article describes novel insights on the mechanism by which cytotoxic chemotherapy drives leukemogenesis (development of therapy-related acute myeloid leukemia and myelodysplastic syndrome).","journal-title":"Nature"},{"key":"274_CR58","doi-asserted-by":"crossref","unstructured":"Majhail NS. Old and new cancers after hematopoietic-cell transplantation. Hematol Am Soc Hematol Educ Program. 2008;142\u20139.","DOI":"10.1182\/asheducation-2008.1.142"},{"issue":"6","key":"274_CR59","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MOH.0000000000000083","volume":"21","author":"RH Rouce","year":"2014","unstructured":"Rouce RH, Louis CU, Heslop HE. Epstein-Barr virus lymphoproliferative disease after hematopoietic stem cell transplant. Curr Opin Hematol. 2014;21(6):476\u201381.","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"274_CR60","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.clml.2013.11.010","volume":"14","author":"MR Luskin","year":"2014","unstructured":"Luskin MR et al. Development of lymphomas containing Epstein-Barr virus after therapy with hyper-CVAD regimen. Clin Lymphoma Myeloma Leuk. 2014;14(2):e55\u20138.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6835","key":"274_CR61","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/bmj.304.6835.1137","volume":"304","author":"AJ Swerdlow","year":"1992","unstructured":"Swerdlow AJ et al. Risk of second primary cancers after Hodgkin\u2019s disease by type of treatment: analysis of 2846 patients in the British national lymphoma investigation. BMJ. 1992;304(6835):1137\u201343.","journal-title":"BMJ"},{"issue":"1","key":"274_CR62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2013.06.041","volume":"109","author":"LA Daniels","year":"2013","unstructured":"Daniels LA et al. Long-term risk of secondary skin cancers after radiation therapy for Hodgkin\u2019s lymphoma. Radiother Oncol. 2013;109(1):140\u20135.","journal-title":"Radiother Oncol"},{"issue":"23","key":"274_CR63","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1182\/blood-2014-05-579193","volume":"124","author":"AK Ng","year":"2014","unstructured":"Ng AK. Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects. Blood. 2014;124(23):3373\u20139. This article summarizes recent recommendations for long-term care of survivors of Hodgkin lymphoma.","journal-title":"Blood"},{"issue":"19","key":"274_CR64","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/jnci\/dji290","volume":"97","author":"LB Travis","year":"2005","unstructured":"Travis LB et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst. 2005;97(19):1428\u201337.","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"274_CR65","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1200\/JCO.2008.20.7738","volume":"27","author":"PD Inskip","year":"2009","unstructured":"Inskip PD et al. Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol. 2009;27(24):3901\u20137.","journal-title":"J Clin Oncol"},{"issue":"26","key":"274_CR66","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1200\/JCO.2008.19.9174","volume":"27","author":"ML Bruin De","year":"2009","unstructured":"De Bruin ML et al. Breast cancer risk in female survivors of Hodgkin\u2019s lymphoma: lower risk after smaller radiation volumes. J Clin Oncol. 2009;27(26):4239\u201346.","journal-title":"J Clin Oncol"},{"issue":"5","key":"274_CR67","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2141.2012.09211.x","volume":"158","author":"B Omer","year":"2012","unstructured":"Omer B et al. Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults. Br J Haematol. 2012;158(5):615\u201325.","journal-title":"Br J Haematol"},{"issue":"21","key":"274_CR68","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","volume":"32","author":"CS Moskowitz","year":"2014","unstructured":"Moskowitz CS et al. Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol. 2014;32(21):2217\u201323. This study defined risk factors for breast cancer among women treated for childhood cancer with chest radiation.","journal-title":"J Clin Oncol"},{"issue":"18","key":"274_CR69","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1200\/JCO.2012.46.5732","volume":"31","author":"AK Ng","year":"2013","unstructured":"Ng AK et al. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol. 2013;31(18):2282\u20138. This study established prospectively the increased sensitivity of combined mammogram plus MRI screening for breast cancer in Hodgkin lymphoma survivors.","journal-title":"J Clin Oncol"},{"issue":"34","key":"274_CR70","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2010.29.5683","volume":"28","author":"MT Milano","year":"2010","unstructured":"Milano MT et al. Long-term survival among patients with Hodgkin\u2019s lymphoma who developed breast cancer: a population-based study. J Clin Oncol. 2010;28(34):5088\u201396.","journal-title":"J Clin Oncol"},{"issue":"7","key":"274_CR71","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/annonc\/mdr551","volume":"23","author":"JD Schoenfeld","year":"2012","unstructured":"Schoenfeld JD et al. Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome. Ann Oncol. 2012;23(7):1813\u20138.","journal-title":"Ann Oncol"},{"issue":"2","key":"274_CR72","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijrobp.2014.06.013","volume":"90","author":"DA Wattson","year":"2014","unstructured":"Wattson DA et al. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys. 2014;90(2):344\u201353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"274_CR73","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/bjc.2012.550","volume":"108","author":"K Behringer","year":"2013","unstructured":"Behringer K et al. Sexual quality of life in Hodgkin lymphoma: a longitudinal analysis by the German Hodgkin study group. Br J Cancer. 2013;108(1):49\u201357.","journal-title":"Br J Cancer"},{"issue":"4","key":"274_CR74","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/bjh.12651","volume":"164","author":"P Greaves","year":"2014","unstructured":"Greaves P et al. Fertility and sexual function in long-term survivors of haematological malignancy: using patient-reported outcome measures to assess a neglected area of need in the late effects clinic. Br J Haematol. 2014;164(4):526\u201335.","journal-title":"Br J Haematol"},{"issue":"4","key":"274_CR75","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.fertnstert.2013.08.018","volume":"100","author":"SJ Falk","year":"2013","unstructured":"Falk SJ, Dizon DS. Sexual dysfunction in women with cancer. Fertil Steril. 2013;100(4):916\u201321. This article represents a comprehensive review of the different causes and treatment modalities for sexual dysfunction for women occuring after cancer treatment.","journal-title":"Fertil Steril"},{"issue":"6","key":"274_CR76","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.seminoncol.2013.09.002","volume":"40","author":"S Goldfarb","year":"2013","unstructured":"Goldfarb S et al. Sexual and reproductive health in cancer survivors. Semin Oncol. 2013;40(6):726\u201344.","journal-title":"Semin Oncol"},{"issue":"28","key":"274_CR77","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1200\/JCO.2013.54.1086","volume":"32","author":"JS Ford","year":"2014","unstructured":"Ford JS et al. Psychosexual functioning among adult female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2014;32(28):3126\u201336.","journal-title":"J Clin Oncol"},{"issue":"3","key":"274_CR78","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000360239","volume":"132","author":"RH Foster","year":"2014","unstructured":"Foster RH, Stern M. Peer and romantic relationships among adolescent and young adult survivors of childhood hematological cancer: a review of challenges and positive outcomes. Acta Haematol. 2014;132(3):375\u201382.","journal-title":"Acta Haematol"},{"key":"274_CR79","doi-asserted-by":"crossref","unstructured":"Kamen C, et al. Disparities in psychological distress impacting lesbian, gay, bisexual and transgender cancer survivors. Psychooncology. 2015. doi: 10.1002\/pon.3746","DOI":"10.1002\/pon.3746"},{"issue":"6","key":"274_CR80","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10815-012-9792-0","volume":"29","author":"P Jadoul","year":"2012","unstructured":"Jadoul P, Kim SS, Committee IP. Fertility considerations in young women with hematological malignancies. J Assist Reprod Genet. 2012;29(6):479\u201387.","journal-title":"J Assist Reprod Genet"},{"issue":"19","key":"274_CR81","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","volume":"31","author":"AW Loren","year":"2013","unstructured":"Loren AW et al. Fertility preservation for patients with cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500\u201310. This article represents a comprehensive review of expert consensus guidelines regarding infertility risks and fertility preservation options for men and women diagnosed with cancer.","journal-title":"J Clin Oncol"},{"issue":"9950","key":"274_CR82","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(14)60834-5","volume":"384","author":"M Vos De","year":"2014","unstructured":"De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer. Lancet. 2014;384(9950):1302\u201310.","journal-title":"Lancet"},{"issue":"9950","key":"274_CR83","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(14)60495-5","volume":"384","author":"H Tournaye","year":"2014","unstructured":"Tournaye H, Dohle GR, Barratt CLR. Fertility preservation in men with cancer. Lancet. 2014;384(9950):1295\u2013301. This article represents a comprehensive review of treatment modalities for men diagnosed with cancer.","journal-title":"Lancet"},{"issue":"6","key":"274_CR84","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/cncr.26459","volume":"118","author":"JM Letourneau","year":"2012","unstructured":"Letourneau JM et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012;118(6):1710\u20137.","journal-title":"Cancer"},{"key":"274_CR85","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7150\/jca.4408","volume":"3","author":"M Scanlon","year":"2012","unstructured":"Scanlon M et al. Patient satisfaction with physician discussions of treatment impact on fertility, menopause and sexual health among pre-menopausal women with cancer. J Cancer. 2012;3:217\u201325.","journal-title":"J Cancer"},{"issue":"3\u20134","key":"274_CR86","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000360199","volume":"132","author":"M Shapira","year":"2014","unstructured":"Shapira M et al. Fertility preservation in young females with hematological malignancies. Acta Haematol. 2014;132(3\u20134):400\u201313.","journal-title":"Acta Haematol"},{"issue":"6","key":"274_CR87","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.clml.2013.05.014","volume":"13","author":"E Assouline","year":"2013","unstructured":"Assouline E et al. Impact of reduced-intensity conditioning allogeneic stem cell transplantation on women\u2019s fertility. Clin Lymphoma Myeloma Leuk. 2013;13(6):704\u201310.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"274_CR88","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1634\/theoncologist.2013-0138","volume":"18","author":"R Paola Di","year":"2013","unstructured":"Di Paola R et al. Anti-Mullerian hormone and antral follicle count reveal a late impairment of ovarian reserve in patients undergoing low-gonadotoxic regimens for hematological malignancies. Oncologist. 2013;18(12):1307\u201314.","journal-title":"Oncologist"},{"issue":"9","key":"274_CR89","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/annonc\/mdu036","volume":"25","author":"Z Blumenfeld","year":"2014","unstructured":"Blumenfeld Z, Katz G, Evron A. \u2018An ounce of prevention is worth a pound of cure\u2019: the case for and against GnRH-agonist for fertility preservation. Ann Oncol. 2014;25(9):1719\u201328.","journal-title":"Ann Oncol"},{"issue":"1","key":"274_CR90","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1200\/JCO.1999.17.1.253","volume":"17","author":"JH Loge","year":"1999","unstructured":"Loge JH et al. Hodgkin\u2019s disease survivors more fatigued than the general population. J Clin Oncol. 1999;17(1):253\u201361.","journal-title":"J Clin Oncol"},{"issue":"12","key":"274_CR91","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1470-2045(09)70258-X","volume":"10","author":"N Heutte","year":"2009","unstructured":"Heutte N et al. Quality of life after successful treatment of early-stage Hodgkin\u2019s lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol. 2009;10(12):1160\u201370.","journal-title":"Lancet Oncol"},{"issue":"3","key":"274_CR92","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejca.2005.09.028","volume":"42","author":"MJ Hjermstad","year":"2006","unstructured":"Hjermstad MJ et al. Quality of life in long-term Hodgkin\u2019s disease survivors with chronic fatigue. Eur J Cancer. 2006;42(3):327\u201333.","journal-title":"Eur J Cancer"},{"issue":"3","key":"274_CR93","doi-asserted-by":"crossref","first-page":"803","DOI":"10.12669\/pjms.293.3290","volume":"29","author":"O Ovayolu","year":"2013","unstructured":"Ovayolu O et al. Symptoms and quality of life: before and after stem cell transplantation in cancer. Pak J Med Sci. 2013;29(3):803\u20138.","journal-title":"Pak J Med Sci"},{"issue":"19","key":"274_CR94","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.291.19.2335","volume":"291","author":"KL Syrjala","year":"2004","unstructured":"Syrjala KL et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA. 2004;291(19):2335\u201343.","journal-title":"JAMA"},{"issue":"6","key":"274_CR95","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/cncr.29149","volume":"121","author":"AR El-Jawahri","year":"2015","unstructured":"El-Jawahri AR et al. Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation. Cancer. 2015;121(6):951\u20139. This represents a prosepctive study of quality of life patients and family caregivers undergoing HSCT; baseline depression and anxiety predicted worse QOL throughout hospitalization.","journal-title":"Cancer"},{"issue":"9","key":"274_CR96","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00520-010-0958-y","volume":"19","author":"CE Mosher","year":"2011","unstructured":"Mosher CE et al. Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Support Care Cancer. 2011;19(9):1357\u201365.","journal-title":"Support Care Cancer"},{"issue":"1","key":"274_CR97","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbmt.2011.05.022","volume":"18","author":"V Gupta","year":"2012","unstructured":"Gupta V et al. A prospective study comparing the outcomes and health-related quality of life in adult patients with myeloid malignancies undergoing allogeneic transplantation using myeloablative or reduced-intensity conditioning. Biol Blood Marrow Transplant. 2012;18(1):113\u201324.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"274_CR98","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/j.seminhematol.2011.10.004","volume":"49","author":"M Norkin","year":"2012","unstructured":"Norkin M, Hsu JW, Wingard JR. Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation. Semin Hematol. 2012;49(1):104\u20139.","journal-title":"Semin Hematol"},{"issue":"4","key":"274_CR99","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bmt.1705434","volume":"38","author":"SJ Lee","year":"2006","unstructured":"Lee SJ et al. Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplant. 2006;38(4):305\u201310.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"274_CR100","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/bmt.2010.5","volume":"45","author":"S Pallua","year":"2010","unstructured":"Pallua S et al. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation. Bone Marrow Transplant. 2010;45(10):1534\u20139.","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"274_CR101","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1182\/blood-2011-04-348730","volume":"118","author":"CL Sun","year":"2011","unstructured":"Sun CL et al. Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the bone marrow transplant survivor study (BMTSS). Blood. 2011;118(17):4723\u201331.","journal-title":"Blood"},{"issue":"4","key":"274_CR102","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0609.2004.00402.x","volume":"74","author":"M Kopp","year":"2005","unstructured":"Kopp M et al. Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls. Eur J Haematol. 2005;74(4):304\u20138.","journal-title":"Eur J Haematol"},{"issue":"13","key":"274_CR103","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1002\/cncr.26645","volume":"118","author":"HS Jim","year":"2012","unstructured":"Jim HS et al. Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation. Cancer. 2012;118(13):3407\u201316.","journal-title":"Cancer"},{"issue":"1","key":"274_CR104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11764-009-0105-2","volume":"4","author":"AC Kirchhoff","year":"2010","unstructured":"Kirchhoff AC, Leisenring W, Syrjala KL. Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. J Cancer Surviv. 2010;4(1):33\u201344.","journal-title":"J Cancer Surviv"},{"issue":"29","key":"274_CR105","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2012.42.6841","volume":"30","author":"KR Krull","year":"2012","unstructured":"Krull KR et al. Neurocognitive function and CNS integrity in adult survivors of childhood Hodgkin lymphoma. J Clin Oncol. 2012;30(29):3618\u201324.","journal-title":"J Clin Oncol"},{"issue":"2","key":"274_CR106","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1200\/JCO.2009.22.5060","volume":"28","author":"RE Goldsby","year":"2010","unstructured":"Goldsby RE et al. Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. J Clin Oncol. 2010;28(2):324\u201331.","journal-title":"J Clin Oncol"},{"issue":"4","key":"274_CR107","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/01.WNL.0000109673.75316.D8","volume":"62","author":"DD Correa","year":"2004","unstructured":"Correa DD et al. Cognitive functions in survivors of primary central nervous system lymphoma. Neurology. 2004;62(4):548\u201355.","journal-title":"Neurology"},{"issue":"3","key":"274_CR108","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11060-008-9716-0","volume":"91","author":"DD Correa","year":"2009","unstructured":"Correa DD et al. Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy. J Neurooncol. 2009;91(3):315\u201321.","journal-title":"J Neurooncol"},{"issue":"10","key":"274_CR109","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1182\/blood-2004-03-1155","volume":"104","author":"KL Syrjala","year":"2004","unstructured":"Syrjala KL et al. Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood. 2004;104(10):3386\u201392.","journal-title":"Blood"},{"issue":"6","key":"274_CR110","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbmt.2010.01.003","volume":"16","author":"JR Basinski","year":"2010","unstructured":"Basinski JR et al. Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant. Biol Blood Marrow Transplant. 2010;16(6):824\u201331.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"274_CR111","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cncr.10627","volume":"95","author":"H Harder","year":"2002","unstructured":"Harder H et al. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer. 2002;95(1):183\u201392.","journal-title":"Cancer"},{"issue":"17","key":"274_CR112","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.2010.33.9119","volume":"29","author":"KL Syrjala","year":"2011","unstructured":"Syrjala KL et al. Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. J Clin Oncol. 2011;29(17):2397\u2013404.","journal-title":"J Clin Oncol"},{"issue":"6","key":"274_CR113","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1200\/JCO.2007.12.3414","volume":"26","author":"SK Smith","year":"2008","unstructured":"Smith SK et al. Post-traumatic stress outcomes in non-Hodgkin\u2019s lymphoma survivors. J Clin Oncol. 2008;26(6):934\u201341.","journal-title":"J Clin Oncol"},{"issue":"2","key":"274_CR114","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/pon.1399","volume":"18","author":"CE Mosher","year":"2009","unstructured":"Mosher CE et al. Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology. 2009;18(2):113\u201327.","journal-title":"Psychooncology"},{"issue":"8","key":"274_CR115","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1200\/JCO.2002.08.757","volume":"20","author":"FR Loberiza Jr","year":"2002","unstructured":"Loberiza Jr FR et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002;20(8):2118\u201326.","journal-title":"J Clin Oncol"},{"issue":"11","key":"274_CR116","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/cncr.27987","volume":"119","author":"A Tichelli","year":"2013","unstructured":"Tichelli A et al. Increase of suicide and accidental death after hematopoietic stem cell transplantation: a cohort study on behalf of the late effects working party of the European group for blood and marrow transplantation (EBMT). Cancer. 2013;119(11):2012\u201321.","journal-title":"Cancer"},{"issue":"23","key":"274_CR117","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1200\/JCO.2009.26.8722","volume":"28","author":"KN DuHamel","year":"2010","unstructured":"DuHamel KN et al. Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation. J Clin Oncol. 2010;28(23):3754\u201361.","journal-title":"J Clin Oncol"},{"issue":"31","key":"274_CR118","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1200\/JCO.2012.47.6705","volume":"31","author":"NK Arora","year":"2013","unstructured":"Arora NK et al. Patient-physician communication about health-related quality-of-life problems: are non-Hodgkin lymphoma survivors willing to talk? J Clin Oncol. 2013;31(31):3964\u201370.","journal-title":"J Clin Oncol"},{"issue":"2","key":"274_CR119","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbmt.2014.06.035","volume":"21","author":"S Hashmi","year":"2015","unstructured":"Hashmi S et al. Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors. Biol Blood Marrow Transplant. 2015;21(2):225\u201332. This article represents a comprehensive review of best-practice guidelines for recipients of hematopoietic cell transplantation, focusing on dedicated long-term follow-up clinics.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"274_CR120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/0009922813483361","volume":"52","author":"R Jesudas","year":"2013","unstructured":"Jesudas R et al. Reviewing the follow-up care of pediatric patients\u2019 status post-hematopoietic stem cell transplantation for the primary care pediatrician. Clin Pediatr (Phila). 2013;52(6):487\u201395.","journal-title":"Clin Pediatr (Phila)"},{"issue":"30","key":"274_CR121","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2012.42.3038","volume":"30","author":"KL Syrjala","year":"2012","unstructured":"Syrjala KL, Martin PJ, Lee SJ. Delivering care to long-term adult survivors of hematopoietic cell transplantation. J Clin Oncol. 2012;30(30):3746\u201351.","journal-title":"J Clin Oncol"},{"issue":"1","key":"274_CR122","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1182\/blood-2010-07-294629","volume":"117","author":"NS Majhail","year":"2011","unstructured":"Majhail NS et al. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood. 2011;117(1):316\u201322.","journal-title":"Blood"},{"key":"274_CR123","doi-asserted-by":"crossref","unstructured":"Marini BL, et al. Treatment of Dyslipidemia in Allogeneic Hematopoietic Stem Cell Transplant Patients. Biol Blood Marrow Transplant. 2014.","DOI":"10.1016\/j.bbmt.2014.10.027"},{"issue":"4","key":"274_CR124","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/pon.3091","volume":"22","author":"JG Hamilton","year":"2013","unstructured":"Hamilton JG et al. Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation. Psychooncology. 2013;22(4):911\u201321.","journal-title":"Psychooncology"},{"issue":"4","key":"274_CR125","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/bmt.2012.123","volume":"48","author":"EM Wulff-Burchfield","year":"2013","unstructured":"Wulff-Burchfield EM, Jagasia M, Savani BN. Long-term follow-up of informal caregivers after allo-SCT: a systematic review. Bone Marrow Transplant. 2013;48(4):469\u201373.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"274_CR126","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.genhosppsych.2014.08.010","volume":"36","author":"SM Virtue","year":"2014","unstructured":"Virtue SM et al. Psychological distress and psychiatric diagnoses among primary caregivers of children undergoing hematopoietic stem cell transplant: an examination of prevalence, correlates, and racial\/ethnic differences. Gen Hosp Psychiatry. 2014;36(6):620\u20136.","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"274_CR127","doi-asserted-by":"crossref","first-page":"e61586","DOI":"10.1371\/journal.pone.0061586","volume":"8","author":"S Beattie","year":"2013","unstructured":"Beattie S, Lebel S, Tay J. The influence of social support on hematopoietic stem cell transplantation survival: a systematic review of literature. PLoS One. 2013;8(4):e61586.","journal-title":"PLoS One"},{"issue":"5","key":"274_CR128","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/1359105313475902","volume":"19","author":"M Bevans","year":"2014","unstructured":"Bevans M et al. A problem-solving education intervention in caregivers and patients during allogeneic hematopoietic stem cell transplantation. J Health Psychol. 2014;19(5):602\u201317.","journal-title":"J Health Psychol"},{"issue":"24","key":"274_CR129","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1200\/JCO.2004.11.032","volume":"22","author":"W Landier","year":"2004","unstructured":"Landier W et al. Development of risk-based guidelines for pediatric cancer survivors: the children\u2019s oncology group long-term follow-up guidelines from the children\u2019s oncology group late effects committee and nursing discipline. J Clin Oncol. 2004;22(24):4979\u201390.","journal-title":"J Clin Oncol"},{"key":"274_CR130","doi-asserted-by":"crossref","unstructured":"Casillas J. et al., Identifying predictors of longitudinal decline in the level of medical care received by adult survivors of childhood cancer: a report from the childhood cancer survivor study. Health Serv Res. 2015. doi: 10.1111\/1475-6773.12282","DOI":"10.1111\/1475-6773.12282"},{"issue":"1","key":"274_CR131","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/0003-4819-160-1-201401070-01001","volume":"160","author":"E Suh","year":"2014","unstructured":"Suh E et al. General internists\u2019 preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey. Ann Intern Med. 2014;160(1):11\u20137.","journal-title":"Ann Intern Med"},{"issue":"5","key":"274_CR132","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2012.46.6854","volume":"31","author":"MS McCabe","year":"2013","unstructured":"McCabe MS et al. American society of clinical oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013;31(5):631\u201340.","journal-title":"J Clin Oncol"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-015-0274-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-015-0274-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-015-0274-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T22:47:50Z","timestamp":1652827670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-015-0274-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,11]]},"references-count":132,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["274"],"URL":"https:\/\/doi.org\/10.1007\/s11899-015-0274-1","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,11]]}}}